Evidence map›Paper›PMID 38371611›Full record

ArticleJournal of community medicine & public health2024

Serotonin Signaling and the Hyperpermeable Endothelial Barrier in Sepsis: Clues to a Molecular Mechanism.

Fusun Kilic

Open access · diamondAbstract read
In one paragraph

Article in Journal of community medicine & public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Fusun KilicBiology Department, Merced College, Merced, California, USA.
Merced College · US

Funding

Communication between platelet SERT and plasma 5HTR01HL091196 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI KILIC, FUSUN · 2009 to 2014
$2.2M
Placental serotonin transporter uses ERp44 and Ero1-L for maturation.R03HD058697 · NICHD · UNIV OF ARKANSAS FOR MED SCIS · PI KILIC, FUSUN · 2009 to 2010
$143k
Impact of Diabetes on Placental Serotonin TransporterR03HD053477 · NICHD · UNIV OF ARKANSAS FOR MED SCIS · PI KILIC, FUSUN · 2006 to 2007
$140k
NHLBI NIH HHS R01 HL091196NICHD NIH HHS R03 HD053477NICHD NIH HHS R03 HD058697
6 · The paper itself

Abstract

Sepsis is characterized by a severe systemic inflammatory response caused by hyperpermeability of the endothelial barrier resulting microvascular leakage, which is a leading factor to multiorgan failure. In sepsis, the hyperpermeable endothelial cells contribute to the activation of platelets, which release numerous mediators that affect coagulation, inflammatory response and are believed to directly or indirectly affect the integrity of the endothelial barrier. One such mediator is serotonin (5-hydroxytryptamine, 5-HT), a signaling molecule which mediates a number of cellular functions including regulation of cytoskeletal dynamics associated with barrier function of endothelial cells. The actions of 5-HT are mediated by different types of receptors and terminated via an uptake mechanism of a 5-HT transporter (SERT) on the platelet and endothelial cell. Earlier studies revealed unexpected discoveries concerning the impact of 5-HT signaling on the permeability of the endothelial barrier. These findings have been supported by the clinical reports on the anti-inflammatory property of 5-HT reuptake inhibitor, SSRIs in treating sepsis-related morbidity and mortality. This review focuses on a wide-range of literature to pinpoint cellular and molecular mechanisms that mediate 5-HT-induced microvascular injury in sepsis pathogenesis.

Indexed as

Endothelial BarrierPlateletsSepsisSerotoninSerotonin signalingSerotonin transporterSSRIs

Identifiers

PMID38371611
PMCPMC10871023
OpenAlexW4389272599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.